Difficulty: Medium
Average Score: 67%
Practice
Acetylcysteine and hypertonic saline are
Correct answer
A
Rationale
The correct answer is A) used cautiously in clients who have hypothyroidism, liver disease, and seizure disorders.
Acetylcysteine and hypertonic saline are both commonly used in respiratory conditions such as cystic fibrosis and chronic obstructive pulmonary disease. Acetylcysteine is a mucolytic agent that helps to break down mucus, while hypertonic saline helps to hydrate airway surfaces and improve mucociliary clearance.
Clients with hypothyroidism, liver disease, and seizure disorders may have underlying conditions that could be exacerbated by these drugs. For example, acetylcysteine can affect thyroid function in patients with hypothyroidism, worsen liver function in individuals with liver disease, and potentially lower the seizure threshold in those with seizure disorders. Therefore, caution is warranted when using these drugs in such individuals.
Option B is incorrect because acetylcysteine and hypertonic saline are not prescribed specifically to hypertensive patients with PTSD. Option C is incorrect as they do not have contraindicating mechanisms of action, rather they have specific considerations for certain patient populations. Option D is also incorrect as they are not both classified as expectorants; while acetylcysteine is an expectorant, hypertonic saline is not classified as one.
In an educational context, understanding the specific patient populations and conditions for which certain drugs need to be used cautiously is crucial for safe and effective patient care. Healthcare providers must be aware of these considerations to prevent adverse effects and optimize patient outcomes when prescribing hematologic drugs like acetylcysteine and hypertonic saline.
Acetylcysteine and hypertonic saline are both commonly used in respiratory conditions such as cystic fibrosis and chronic obstructive pulmonary disease. Acetylcysteine is a mucolytic agent that helps to break down mucus, while hypertonic saline helps to hydrate airway surfaces and improve mucociliary clearance.
Clients with hypothyroidism, liver disease, and seizure disorders may have underlying conditions that could be exacerbated by these drugs. For example, acetylcysteine can affect thyroid function in patients with hypothyroidism, worsen liver function in individuals with liver disease, and potentially lower the seizure threshold in those with seizure disorders. Therefore, caution is warranted when using these drugs in such individuals.
Option B is incorrect because acetylcysteine and hypertonic saline are not prescribed specifically to hypertensive patients with PTSD. Option C is incorrect as they do not have contraindicating mechanisms of action, rather they have specific considerations for certain patient populations. Option D is also incorrect as they are not both classified as expectorants; while acetylcysteine is an expectorant, hypertonic saline is not classified as one.
In an educational context, understanding the specific patient populations and conditions for which certain drugs need to be used cautiously is crucial for safe and effective patient care. Healthcare providers must be aware of these considerations to prevent adverse effects and optimize patient outcomes when prescribing hematologic drugs like acetylcysteine and hypertonic saline.